stella
beta
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL) — Stella
Recruiting
Back to Chronic Lymphocytic Leukemia (CLL) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(8 sites)
United States
Northwestern University, Evanston, Illinois
Massachusetts General Hospital (Data Collection and Specimen Analysis), Boston, Massachusetts
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey
Memorial Sloan Kettering Monmouth, Middletown, New Jersey
Memorial Sloan Kettering Commack, Commack, New York
Show all 8 locations
View full record on ClinicalTrials.gov